Endocrine and Metabolic Comorbidities in Juvenile-Onset Systemic Lupus Erythematosus
February 2025
in “
Frontiers in Medicine
”
Studysummary This study found that patients with juvenile-onset systemic lupus erythematosus have a high prevalence of endocrine and metabolic comorbidities, particularly dyslipidemia and obesity-related issues, suggesting the need for routine monitoring and obesity prevention.
Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
Patients with juvenile-onset systemic lupus erythematosus (JSLE) experience a higher incidence of endocrine and metabolic comorbidities. Regular monitoring of these patients is recommended to manage and potentially reduce these health burdens. Additionally, preventing obesity in JSLE patients may be beneficial in decreasing the risk of developing these comorbid conditions.